A risk score based on baseline risk factors for predicting mortality in COVID-19 patients

Ze Chen, Jing Chen, Jianghua Zhou, Fang Lei, Feng Zhou, Juan‐Juan Qin, Xiao‐Jing Zhang, Lihua Zhu, Ye-Mao Liu, Haitao Wang,

Current Medical Research and Opinion · 2021 · 22 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND: To develop a sensitive and clinically applicable risk assessment tool identifying coronavirus disease 2019 (COVID-19) patients with a high risk of mortality at hospital admission. This model would assist frontline clinicians in optimizing medical treatment with limited resources. METHODS: 6415 patients from seven hospitals in Wuhan city were assigned to the training and testing cohorts. A total of 6351 patients from another three hospitals in Wuhan, 2169 patients from outside of Wuhan, and 553 patients from Milan, Italy were assigned to three independent validation cohorts. A total of 64 candidate clinical variables at hospital admission were analyzed by random forest and least absolute shrinkage and selection operator (LASSO) analyses. RESULTS: < .0001). The predictive performance, specificity, and sensitivity of the score were validated in three independent cohorts. CONCLUSIONS: The OURMAPCN score is a risk assessment tool to determine the mortality rate in COVID-19 patients based on a limited number of baseline parameters. This tool can assist physicians in optimizing the clinical management of COVID-19 patients with limited hospital resources.

References

36